The Vaccine Safety Datalink (VSD) is a large, linked database of patient information that was developed jointly by CDC and several private managed care organizations in 1991. It includes data on vaccination histories, health outcomes, and characteristics of more than 7 million patients of eight participating health organizations. Researchers from CDC and the managed care groups have used VSD information to study whether health problems are associated with vaccinations. The subsequent VSD data sharing program was launched in 2002 to allow independent, external researchers access to information in the database. In this report, the committee that was asked to review aspects of this program recommends that two new oversight groups are needed to ensure that the policies and procedures of the VSD and its data sharing program are implemented as fairly and openly as possible.
Committee on the Review of the National Immunization Program's Research Procedures and Data Sharing Program
1 Front Matter; 2 Executive Summary; 3 1 Study Background and Contextual Issues; 4 2 Description of the Vaccine Safety Datalink; 5 3 The Vaccine Safety Datalink Data Sharing Program; 6 4 The Vaccine Safety Datalink Research Process and the Release of Preliminary Findings; 7 5 Independent Review of Vaccine Safety Datalink Activities; 8 Concluding Remarks; 9 References; 10 Appendix A Committee Biographies; 11 Appendix B Glossary; 12 Appendix C Acronyms; 13 Appendix D Meeting One-Agenda; 14 Appendix E Meeting Two-Agenda; 15 Appendix F Summary of Public Submissions; 16 Appendix G Notice and Request for Comment on Procedures and Costs for Use of the Research Data Center
National Research Council, Division of Behavioral and Social Sciences and Education, Institute of Medicine, and Families Board on Children, Youth, Steve Olson
Institute of Medicine, Board on the Health of Select Populations, and Transgender Health Issues and Research Gaps and Opportunities Committee on Lesbian, Gay, Bisexual
Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health
Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie McCormick, Padma Shetty, Alicia Gable, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Theresa Wizemann, Donna A. Alamario, Kathleen Stratton
Institute of Medicine, Board on Global Health, Board on Population Health and Public Health Practice, Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Lonnie King, Rose Marie Martinez, Tracy Lieu, Dennis Fryback, Charles Phelps, Kinpritma Sangha, Guruprasad Madharan
and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C, Brian L. Strom, Gillian J. Buckley
Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee to Study Priorities for Vaccine Development, Robert S. Lawrence, Jane S. Durch, Kathleen R. Stratton
Institute of Medicine, Division of Health Promotion and Disease Prevention, Committee on the Elimination of Tuberculosis in the United States, Lawrence Geiter
Institute of Medicine, Division of Health Promotion and Disease Prevention, Division of Health Care Services, Committee on Immunization Finance Policies and Practices
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Alicia Gable, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Christopher B. Wilson, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Alicia Gable, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Donna A. Almario, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie C. McCormick, Theresa M. Wizemann, Donna A. Almario, Kathleen Stratton
Institute of Medicine, Board on Health Promotion and Disease Prevention, Immunization Safety Review Committee, Marie McCormick, Padma Shetty, Alicia Gable, Kathleen Stratton
Institute of Medicine, Board on Global Health, Board on Population Health and Public Health Practice, Phase II Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Institute Of Medicine, Board On Global Health, Committee on Identifying and Prioritizing New Preventive Vaccines for Development Phase II, Lonnie King, Rose Marie Martinez, Rino Rappuoli, Dennis Fryback, Charles Phelps, Kinpritma Sangha, Guruprasad Madhavan
National Academy of Engineering, Institute of Medicine, Board on Global Health, Board on Population Health and Public Health Practice, Phase III Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Lonnie King, Rose Marie Martinez, Rino Rappuoli, Charles Phelps, Guruprasad Madhavan
Institute of Medicine, Board on Population Health and Public Health Practice, Committee to Review Adverse Effects of Vaccines, Ellen Wright Clayton, Erin Rusch, Andrew Ford, Kathleen Stratton
Institute of Medicine, Division of Health Promotion and Disease Prevention, Division of Health Care Services, Committee on Immunization Finance Policies and Practices